Prosecution Insights
Last updated: April 19, 2026

Allergan, Inc.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
2
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18599800 USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION AZPURU, CARLOS A 1617 Non-Final OA Mar 08, 2024
18431278 DUAL CAP SYSTEM FOR CONTAINER-CLOSURES TO MAINTAIN TIP STERILITY DURING SHELF STORAGE DAVISON, LAURA L 3993 Non-Final OA Feb 02, 2024
18304884 IMPLANT IDENTIFICATION BY RADIOGRAPHIC MEANS ZIMMERMAN, REBECCA LYNEE 3774 Non-Final OA Apr 21, 2023
18015136 TISSUE EXPANSION DEVICE WITH FLUID COLLECTION DUDDEN, TERESA MARIE 3774 Final Rejection Jan 09, 2023
17811217 METHODS AND APPARATUS FOR DELIVERY OF OCULAR IMPLANTS MEHTA, BHISMA 3783 Non-Final OA Jul 07, 2022
17789159 PHYSICAL MIX HA-COLLAGEN DERMAL FILLERS SHIAO, YIH-HORNG 1691 Non-Final OA Jun 24, 2022
17789162 CROSSLINKED HA-COLLAGEN HYDROGELS AS DERMAL FILLERS ISNOR, ALEXANDRA NICOLE 1611 Final Rejection Jun 24, 2022

Managing Allergan, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month